kidney
Advertisement
Novartis and Versant are forming Borealis Biosciences, a biotech company focused on medicines for kidney diseases.
The American Nephrology Nurses Association (ANNA) 2024 Nephrology Nursing Summit will take place September 16-18, 2024.
Sponsored content: Qasim Butt, MD, describes the importance of hyperkalemia management and how LOKELMA can help.
Carlyle has agreed to acquire the kidney care segment of Baxter International Inc., to be called Vantive, for $3.8B.
Researchers examined data of patients starting kidney replacement therapy for ESRD due to primary glomerular disease.
The VALIANT phase 3 trial produced positive results for the use of systemic pegcetacoplan in patients with C3G or IC-IMPGN.
Researchers assessed the landscape of QSP modeling and developed a use case for QSP to determine hyperkalemia risk.
Interwell Health has more than 2000 nephrologists in its provider network, making it the largest in value-based kidney care.
It's time for another NephJC draft! This time the 2024 KDIGO CKD guideline draft is on the clock!
Kidney care provider Evergreen Nephrology has added David Young to its board of directors.
A gift from the Schattner Foundation will support the American Kidney Fund's disaster relief program and other programs.
The American Heart Association has launched a 4-year plan to improve awareness and treatment of CKM syndrome.
Anjay Rastogi, MD, PhD, spoke about findings from the ZORA study regarding the efficacy of SZC for hyperkalemia.
Kidney care services provider Fresenius Medical Care has entered into five wind and solar power purchase agreements.
A survey found health care professionals lack knowledge about the relationship between climate change and kidney health.
Could SZC use allow for quick and safe initiation and titration of MRAs and long-term optimal dosing for patients with HRrEF?
Researchers studied a large pediatric patient cohort on hemodialysis to learn more about cardiovascular risk factors.
What influence does hyperkalemia have on disease severity and mortality risk among patients admitted to the emergency room?
Researchers studied how race, ethnicity, and other demographic factors relate to the risk of recurrent hyperkalemia.
SGLT2i are associated with a significant reduction of proteinuria, especially for patients with higher BMI.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.